Login / Signup

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.

Romina LomonacoEddison Godinez LeivaFernando BrilSulav ShresthaLydia MansourJeff BuddJessica Portillo RomeroSiegfried SchmidtKu-Lang ChangGeorge SamrajJohn MalatyKatherine HuberPierre BedossaSrilaxmi KalavalapalliJonathan MarteDiana BarbDanielle PoultonNada FanousKenneth Cusi
Published in: Diabetes care (2020)
Moderate-to-advanced fibrosis (F2 or higher), an established risk factor for cirrhosis and overall mortality, affects at least one out of six (15%) patients with T2DM. These results support the American Diabetes Association guidelines to screen for clinically significant fibrosis in patients with T2DM with steatosis or elevated ALT.
Keyphrases
  • liver fibrosis
  • glycemic control
  • type diabetes
  • cardiovascular disease
  • insulin resistance
  • cardiovascular events
  • high fat diet
  • clinical practice
  • risk factors
  • metabolic syndrome
  • skeletal muscle
  • high fat diet induced